Holly joined The Cooper Companies as Executive Vice President & Chief Strategy Officer in June 2018. She was named President of CooperSurgical in July 2020. Prior to joining Cooper, Holly had over 20 years of experience in investment banking, with a focus on medical equipment and technology. From 2009 to 2018 she was a Managing Director, Global Head of Medical Technology at UBS Securities. Holly was at Donaldson, Lufkin & Jenrette from 1997-2000 until it was acquired by Credit Suisse where she stayed on until 2009. Holly was graduated from Cornell University with a BS, and obtained an MBA from Columbia Business School.